Global Vitro Toxicology Testing Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2024 –2030 |
 Tamaño del mercado (año base) |
|
 Tamaño del mercado (año de pronóstico) |
USD 27,952.36 |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
|
>Mercado global de pruebas de toxicología in vitro, por producto y servicio (consumibles, servicios, ensayos, equipos y software), punto final y prueba de toxicología (pruebas ADME (absorción, distribución, metabolismo y excreción), pruebas de citotoxicidad, pruebas de genotoxicidad, pruebas de toxicidad dérmica, pruebas de toxicidad ocular, pruebas de toxicidad de órganos, pruebas de irritación, corrosión y sensibilización de la piel, pruebas de fototoxicidad y otros puntos finales y pruebas de toxicidad), tecnología (tecnologías de cultivo celular, tecnologías de alto rendimiento, imágenes moleculares y tecnología ómica), método (ensayos celulares, ensayos bioquímicos, modelos ex vivo y modelos in silico), industria (empresas farmacéuticas y biofarmacéuticas, diagnósticos, alimentos, productos químicos, cosméticos y productos para el hogar), canal de distribución (licitación directa, ventas minoristas y otros) - Tendencias de la industria y pronóstico 2030.
Análisis y tamaño del mercado de pruebas de toxicología in vitro
El mercado mundial de pruebas de toxicología in vitro está fragmentado por naturaleza, ya que consta de muchos actores globales como Thermo Fisher Scientific Inc. (EE. UU.), Labcorp Drug Development (EE. UU.), Merck KGaA (Alemania), Charles River Laboratories (EE. UU.) y Lonza (Suiza), entre otros. La presencia de estas empresas produce precios competitivos para los productos de pruebas de toxicología in vitro en toda la región. Debido a la presencia de estos actores a nivel regional e internacional, los proveedores y fabricantes ofrecen productos con diferentes especificaciones y características para todos los presupuestos. La creciente demanda de productos de pruebas de toxicología in vitro a nivel mundial impulsa el crecimiento del mercado. Además, se espera que las industrias farmacéutica y médica de rápido crecimiento impulsen el crecimiento del mercado.
Data Bridge Market Research analiza que se espera que el mercado mundial de pruebas de toxicología in vitro alcance los 27.952,36 millones de dólares en 2030, con una tasa de crecimiento anual compuesta (CAGR) del 12,3 % durante el período de pronóstico. Este informe de mercado también cubre en profundidad el análisis de precios y los avances tecnológicos.
|
Métrica del informe |
Detalles |
|
Período de pronóstico |
2023 a 2030 |
|
Año base |
2022 |
|
Años históricos |
2021 (Personalizable para 2015 - 2020) |
|
Unidades cuantitativas |
Ingresos en millones de USD, volúmenes en unidades y precios en USD |
|
Segmentos cubiertos |
By Product and Service (Consumables, Services, Assays, Equipments, and Software), Toxicology End Point and Test (ADME (Absorption, Distribution, Metabolism, & Excretion) Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity Testing, Ocular Toxicity Testing, Organ Toxicity Testing, Skin Irritation, Corrosion, & Sensitization Testing, Phototoxicity Testing, and Other Toxicity Endpoints & Tests), Technology (Cell Culture, High-Throughput Technologies, Molecular Imaging, and Omics Technology), Method (Cellular Assays, Biochemical Assays, Ex-Vivo Models, and In Silico Models), Industry (Pharmaceutical & Biopharmaceutical Companies, Diagnostics, Food, Chemicals, Cosmetics & Household Products), Distribution Channel (Direct Tender, Retail Sales, and Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa |
|
Market Players Covered |
Thermo Fisher Scientific Inc., Labcorp Drug Development, Merck KGaA, Charles River Laboratories, Lonza, Bio-Rad Laboratories, Inc., Catalent, Inc, SGS Société Générale de Surveillance SA, QIAGEN, Intertek Group plc., Eurofins Scientific, Promega Corporation, Aragen Life Sciences Ltd., Cyprotex Plc., Shanghai Medicilon Inc., Creative Biolabs, BioIVT, AAT Bioquest, Inc., Gentronix, IONTOX, InSphero, MB Research Laboratories, Creative Bioarray, and Preferred Cell Systems |
Market Definition
In-vitro toxicology testing involves testing chemicals, drugs, and other substances to assess their potential toxicity using in-vitro (non-animal) testing methods. In-vitro toxicology testing involves using cells, tissues, or cellular components outside their natural environment to evaluate substances' safety and potential hazards. The market encompasses a wide range of in-vitro tests and assays that assess various aspects of toxicity, including but not limited to cytotoxicity, genotoxicity, carcinogenicity, organ toxicity, reproductive toxicity, and environmental toxicity. These tests are conducted on cell cultures, tissue models, or other in-vitro systems to mimic the response of biological systems to potential toxicants.
Global In-Vitro Toxicology Testing Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
Increasing demand for toxicology testing products
The main activity of the pharmaceutical industry is quality management. Drugs must be sold as formulations that are sterile, therapeutically active, reliable, and predictable in their performance. New and improved medicinal agents are being developed at an accelerated speed. At the same time, more exact and sophisticated analytical methods are being developed for their evaluation. The Food and Drug Administration has issued several guidance documents for industry, such as safety testing of drug metabolites, in-vitro metabolism and transporter-mediated drug-drug interaction studies, and clinical drug interactions studies.
There is a need for sterile medical products for patient safety, along with safeguarding pharmaceutical and medical device companies from a product recall, further escalating the market demand. Therefore, increasing demand for toxicology testing products in the pharmaceutical and biotechnology industry drives the growth of the market.
Rapidly growing pharmaceutical and medical device industry
Many revolutionary trends and advances have been witnessed by the pharmaceutical and medical device industries, dramatically improving the medicines available to patients globally. It was possible to witness the effect of artificial intelligence and big data on the diagnosis and treatment of diseases.
Combined with their potential to remedy previously untreatable diseases, biopharmaceutical drugs' effectiveness, and protection help pharmaceutical companies succeed. An opportunity for sustained healthy growth supports the existing biologics-development pipeline. Since 1995, the number of biotech patents applied annually has increased by 25%. More than 1,500 biomolecules are presently undergoing clinical trials, and the biologics success rate has so far been more than double that of small-molecule drugs, with 13% of biopharmaceuticals entering the phase I testing phase going on to launch.
The prosperity and growth of these industries proportionally increase the demand for toxicity testing for the quality control of the products developed by them. Therefore, the rapidly growing pharmaceutical and medical device industries act as a driver for the growth of the market.
OPPORTUNITY
Growing adoption of quality check products to prevent product recalls
Medical devices, drugs, and biologics are increasingly important in today's healthcare delivery. However, ongoing quality concerns with drugs and related recalls raise possible health hazards to the use these drugs on patients. One of the major reasons for product recall in pharmaceutical companies is the toxicity profile of their drugs and other products, which could pose serious health complications among the patients who consume them.
In-process controls to track the existence of toxicity must include the aseptic production of compounded products. Therefore, effective and efficient monitoring for toxicity is important in the pharmaceutical and biomedical industries. All injectable or implantable products labeled as pyrogen-free or sterile must undergo toxicology testing before release. This avoids toxicity in patients and makes it easy to comply with regulatory and cGMP guidelines. Hence, the growing adoption of quality check products to prevent product recalls acts as an opportunity for market growth.
RESTRAINT / CHALLENGE
High cost associated with in-vitro toxicology testing and products
Automated toxicity testing systems are equipped with the latest technology and advanced features. They have wide functionalities and features. The automated AST gives efficient and accurate detection of toxicity. However, the high cost of these devices is likely to impact the market.
Thus, the advancement comprises of automated antimicrobial susceptibility testing (AST), Microdilution, rapid automated instrument methods, MIC strip tests, genotypic methods, disk diffusion method, e-tests, and POCT-compatible technologies, all these advanced features make the device costly. This may act as a restraining factor for the in-vitro toxicology testing market.
Recent Development
- In June 2023, Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, announced it had acquired Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage technology platform for developing ADCs. This will help the company to expand their global presence
- In October 2022, Thermo Fisher Scientific Inc. announced that it will expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development. This helped the company to expand its clinical diagnostics business across various regions in the world and helped to increase its global presence in the market
Global In-Vitro Toxicology Testing Market Scope
The global in-vitro toxicology testing market is segmented into six notable segments: product and service, toxicology end point and test, technology, method, industry, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Product and Service
- Consumables
- Services
- Assay
- Equipments
- Software
Based on product and service, the global in-vitro toxicology testing market is segmented into consumables, services, assays, equipments, and software.
Toxicology End Point and Test
- ADME (Absorption, Distribution, Metabolism, & Excretion) Testing
- Cytotoxicity Testing
- Genotoxicity Testing
- Dermal Toxicity Testing
- Ocular Toxicity Testing
- Organ Toxicity Testing
- Skin Irritation, Corrosion, & Sensitization Testing
- Phototoxicity Testing, and Other Toxicity Endpoints & Test
Based on toxicology end point and test, the market is segmented into ADME (absorption, distribution, metabolism, & excretion) testing, cytotoxicity testing, genotoxicity testing, dermal toxicity testing, ocular toxicity testing, organ toxicity testing, skin irritation, corrosion, & sensitization testing, phototoxicity testing, and other toxicity endpoints & tests.
Technology
- Cell Culture Technologies
- High-Throughput Technologies
- Molecular Imaging
- OMICS Technology
Based on technology, the market is segmented into cell culture technologies, high-throughput technologies, molecular imaging, and OMICS technology.
Method
- Cellular Assays
- Biochemical Assays
- Ex-Vivo Models
- In Silico Models
Based on method the market is segmented into cellular assays, biochemical assays, ex-vivo models, and in silico models.
Industry
- Pharmaceutical & Biopharmaceutical Companies
- Diagnostics
- Food
- Chemicals
- Cosmetics & Household Products
Based on industry the market is segmented into pharmaceutical & biopharmaceutical companies, diagnostics, food, chemicals, cosmetics & household products.
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Based on distribution channel, the market is segmented into direct tender, retail sales, and others.
Global In-Vitro Toxicology Testing Market Regional Analysis/Insights
The global in-vitro toxicology testing market is analyzed. As referenced above, market size insights and trends are provided by country, product and service, toxicology end point and test, technology, method, industry and distribution channel.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
North America is expected to dominate due to rising demand for toxicology testing, and technological advancements are anticipated to fuel the market growth during the forecast period in this region. The U.S. is expected to dominate North America due to rising demand for in-vitro toxicology testing products. China is expected to dominate Asia-Pacific as the strategic initiatives by the key market players are expanding significantly. Germany is expected to dominate Europe due to the rapidly growing pharmaceutical and medical industries.
La sección de países del informe también proporciona factores individuales que impactan en el mercado y cambios en la regulación del mercado que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como el análisis de la cadena de valor aguas abajo y aguas arriba, las tendencias técnicas, el análisis de las cinco fuerzas de Porter y los estudios de casos son algunos indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.
Análisis del panorama competitivo y de la cuota de mercado global de las pruebas de toxicología in vitro
El panorama competitivo del mercado mundial de pruebas de toxicología in vitro proporciona detalles sobre los competidores. Los detalles incluyen una descripción general de la empresa, información financiera, ingresos generados, potencial de mercado, nuevas iniciativas de mercado, presencia global, sitios e instalaciones de producción, capacidades de producción, fortalezas y debilidades de la empresa, lanzamiento de productos, amplitud y variedad de productos y dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.
Algunos de los principales actores del mercado que operan en el mercado global de pruebas de toxicología in vitro son Thermo Fisher Scientific Inc. (EE. UU.), Labcorp Drug Development (EE. UU.), Merck KGaA (Alemania), Charles River Laboratories (EE. UU.), Lonza (Suiza), Bio-Rad Laboratories, Inc. (EE. UU.), Catalent, Inc (EE. UU.), SGS Société Générale de Surveillance SA (Suiza), QIAGEN (Alemania), Intertek Group plc. (Reino Unido), Eurofins Scientific (Luxemburgo), Promega Corporation (EE. UU.), Aragen Life Sciences Ltd. (India), Cyprotex Plc. (Reino Unido), Shanghai Medicilon Inc. (China), Creative Biolabs (EE. UU.), BioIVT (EE. UU.), AAT Bioquest, Inc. (EE. UU.), Gentronix (Reino Unido), IONTOX (EE. UU.), InSphero (EE. UU.), MB Research Laboratories (EE. UU.), Creative Bioarray (EE. UU.) y Preferred Cell Systems (EE. UU.), entre otros.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS ANALYSIS
5 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS
6 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR TOXICOLOGY TESTING PRODUCTS
7.1.2 RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
7.1.3 RISING INVESTMENT IN R&D BY KEY MARKET PLAYERS
7.1.4 TECHNOLOGICAL ADVANCEMENTS TO DEVELOP NEW TOXICOLOGY TESTING METHODS
7.2 RESTRAINTS
7.2.1 HIGH COSTS ASSOCIATED WITH IN-VITRO TOXICOLOGY TESTING AND PRODUCTS
7.2.2 COMPLEXITY OF BIOLOGICAL SYSTEMS
7.2.3 NEED FOR SKILLED PERSONNEL AND INFRASTRUCTURE
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF QUALITY CHECK PRODUCTS TO PREVENT PRODUCT RECALLS
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS FOR MARKET EXPANSION
7.3.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND PRECISION TOXICOLOGY
7.4 CHALLENGES
7.4.1 ETHICAL AND PUBLIC PERCEPTION
7.4.2 REGULATORY ACCEPTANCE AND ENDORSEMENT OF IN-VITRO TESTING METHODS
8 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 CONSUMABLES
8.3 SERVICES
8.3.1 CYTOTOXICITY
8.3.2 GENE TOXICITY
8.3.3 HEPATOTOXICITY
8.3.4 OPHTHALMIC TOXICITY
8.3.5 CARDIOTOXICITY
8.3.6 NEPHROTOXICITY
8.3.7 NEUROTOXICITY
8.3.8 OTHERS
8.4 ASSAYS
8.4.1 CELL-BASED ELISA & WESTERN BLOTS
8.4.2 ENZYME TOXICITY ASSAYS
8.4.3 RECEPTOR-BINDING ASSAYS
8.4.4 BACTERIAL TOXICITY ASSAYS
8.4.5 TISSUE CULTURE ASSAYS
8.4.6 OTHER ASSAYS
8.5 EQUIPMENTS
8.6 SOFTWARE
9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST
9.1 OVERVIEW
9.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
9.3 CYTOTOXICITY TESTING
9.4 GENOTOXICITY TESTING
9.5 DERMAL TOXICITY TESTING
9.6 OCULAR TOXICITY TESTING
9.7 ORGAN TOXICITY TESTING
9.8 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
9.9 PHOTOTOXICITY TESTING
9.1 OTHER TOXICITY ENDPOINTS AND TESTS
10 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 CELL CULTURE TECHNOLOGIES
10.3 HIGH-THROUGHPUT TECHNOLOGIES
10.4 MOLECULAR IMAGING
10.5 OMICS TECHNOLOGY
11 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD
11.1 OVERVIEW
11.2 CELLULAR ASSAYS
11.3 BIOCHEMICAL ASSAYS
11.4 EX-VIVO MODELS
11.5 IN SILICO MODELS
12 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
12.2.1 CONSUMABLES
12.2.2 SERVICES
12.2.3 ASSAYS
12.2.4 EQUIPMENTS
12.2.5 SOFTWARE
12.3 DIAGNOSTICS
12.3.1 CONSUMABLES
12.3.2 SERVICES
12.3.3 ASSAYS
12.3.4 EQUIPMENTS
12.3.5 SOFTWARE
12.4 FOOD
12.4.1 CONSUMABLES
12.4.2 SERVICE
12.4.3 ASSAYS
12.4.4 EQUIPMENTS
12.4.5 SOFTWARE
12.5 CHEMICALS
12.5.1 CONSUMABLES
12.5.2 SERVICES
12.5.3 ASSAYS
12.5.4 EQUIPMENTS
12.5.5 SOFTWARE
12.6 COSMETICS AND HOUSEHOLD PRODUCTS
12.6.1 CONSUMABLES
12.6.2 SERVICES
12.6.3 ASSAYS
12.6.4 EQUIPMENTS
12.6.5 SOFTWARE
13 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION
14.1 OVERVIEW
14.2 NORTH AMERICA
14.2.1 U.S.
14.2.2 CANADA
14.2.3 MEXICO
14.3 EUROPE
14.3.1 GERMANY
14.3.2 U.K.
14.3.3 FRANCE
14.3.4 ITALY
14.3.5 RUSSIA
14.3.6 SPAIN
14.3.7 NETHERLANDS
14.3.8 2.8 SWITZERLAND
14.3.9 BELGIUM
14.3.10 TURKEY
14.3.11 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.2 JAPAN
14.4.3 INDIA
14.4.4 AUSTRALIA
14.4.5 SOUTH KOREA
14.4.6 INDONESIA
14.4.7 PHILIPPINES
14.4.8 THAILAND
14.4.9 MALAYSIA
14.4.10 SINGAPORE
14.4.11 REST OF ASIA-PACIFIC
14.5 SOUTH AMERICA
14.5.1 BRAZIL
14.5.2 ARGENTINA
14.5.3 REST OF SOUTH AMERICA
14.6 MIDDLE EAST AND AFRICA
14.6.1 SAUDI ARABIA
14.6.2 SOUTH AFRICA
14.6.3 U.A.E.
14.6.4 EGYPT
14.6.5 ISRAEL
14.6.6 REST OF MIDDLE EAST AND AFRICA
15 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 LABCORP DRUG DEVELOPMENT
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 CHARLES RIVER LABORATORIES.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 LONZA
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AAT BIOQUEST, INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ARAGEN LIFE SCIENCES LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BIOIVT
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO-RAD LABORATORIES, INC.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 CATALENT, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 CREATIVE BIOARRAY.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 CREATIVE BIOLABS.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 CYPROTEX LIMITED
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 EUROFINS SCIENTIFIC
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 GENTRONIX
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 IONTOX
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 INSPHERO.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 INTERTEK GROUP PLC
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 MB RESEARCH LABORATORIES
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 PREFERRED CELL SYSTEMS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PROMEGA CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 QIAGEN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 SHANGHAI MEDICILON INC.
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Lista de Tablas
TABLE 1 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL CONSUMABLES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL EQUIPMENT IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL SOFTWARE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL CYTOTOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL GENOTOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL DERMAL TOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL OCULAR TOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL ORGAN TOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL PHOTOTOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL OTHER TOXICITY ENDPOINTS AND TESTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL CELL CULTURE TECHNOLOGIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL HIGH-THROUGHPUT TECHNOLOGIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL MOLECULAR IMAGING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 GLOBAL OMICS TECHNOLOGY IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 25 GLOBAL CELLULAR ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 GLOBAL BIOCHEMICAL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 GLOBAL EX-VIVO MODELS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 GLOBAL IN SILICO MODELS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 30 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 32 GLOBAL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 GLOBAL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 34 GLOBAL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 GLOBAL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 36 GLOBAL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 GLOBAL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 38 GLOBAL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 GLOBAL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 40 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 GLOBAL DIRECT TENDER IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 GLOBAL RETAIL SALES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 GLOBAL OTHERS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 59 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 60 U.S. SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 61 U.S. ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 62 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 63 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 64 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 65 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 66 U.S. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 67 U.S. DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 68 U.S. FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 69 U.S. CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 70 U.S. COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 71 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 73 CANADA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 74 CANADA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 75 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 76 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 77 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 78 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 79 CANADA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 80 CANADA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 81 CANADA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 82 CANADA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 83 CANADA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 84 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 85 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 86 MEXICO SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 87 MEXICO ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 88 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 89 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 90 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 91 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 92 MEXICO PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 93 MEXICO DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 94 MEXICO FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 95 MEXICO CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 96 MEXICO COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 97 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 98 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 99 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 100 EUROPE SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 101 EUROPE ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 102 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 103 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 104 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 105 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 106 EUROPE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 107 EUROPE DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 108 EUROPE FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 109 EUROPE CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 110 EUROPE COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 111 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 112 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 113 GERMANY SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 114 GERMANY ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 115 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 116 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 117 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 118 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 119 GERMANY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 120 GERMANY DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 121 GERMANY FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 122 GERMANY CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 123 GERMANY COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 124 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 126 U.K. SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 127 U.K. ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 128 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 129 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 130 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 131 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 132 U.K. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 133 U.K. DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 134 U.K. FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 135 U.K. CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 136 U.K. COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 137 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 138 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 139 FRANCE SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 140 FRANCE ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 141 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 142 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 143 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 144 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 145 FRANCE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 146 FRANCE DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 147 FRANCE FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 148 FRANCE CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 149 FRANCE COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 150 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 151 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 152 ITALY SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 153 ITALY ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 154 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 155 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 156 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 157 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 158 ITALY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 159 ITALY DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 160 ITALY FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 161 ITALY CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 162 ITALY COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 163 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 164 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 165 RUSSIA SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 166 RUSSIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 167 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 168 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 169 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 170 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 171 RUSSIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 172 RUSSIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 173 RUSSIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 174 RUSSIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 175 RUSSIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 176 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 178 SPAIN SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 179 SPAIN ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 180 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 181 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 182 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 183 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 184 SPAIN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 185 SPAIN DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 186 SPAIN FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 187 SPAIN CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 188 SPAIN COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 189 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 190 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 191 NETHERLANDS SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 192 NETHERLANDS ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 193 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 194 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 195 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 196 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 197 NETHERLANDS PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 198 NETHERLANDS DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 199 NETHERLANDS FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 200 NETHERLANDS CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 201 NETHERLANDS COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 202 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 203 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 204 SWITZERLAND SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 205 SWITZERLAND ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 206 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 207 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 208 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 209 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 210 SWITZERLAND PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 211 SWITZERLAND DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 212 SWITZERLAND FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 213 SWITZERLAND CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 214 SWITZERLAND COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 215 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 216 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 217 BELGIUM SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 218 BELGIUM ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 219 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 220 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 221 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 222 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 223 BELGIUM PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 224 BELGIUM DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 225 BELGIUM FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 226 BELGIUM CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 227 BELGIUM COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 228 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 229 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 230 TURKEY SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 231 TURKEY ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 232 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 233 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 234 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 235 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 236 TURKEY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 237 TURKEY DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 238 TURKEY FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 239 TURKEY CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 240 TURKEY COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 241 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 242 REST OF EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 243 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 244 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 245 ASIA-PACIFIC SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 246 ASIA-PACIFIC ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 247 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 248 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 249 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 250 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 251 ASIA-PACIFIC PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 252 ASIA-PACIFIC DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 253 ASIA-PACIFIC FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 254 ASIA-PACIFIC CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 255 ASIA-PACIFIC COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 256 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 257 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 258 CHINA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 259 CHINA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 260 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 261 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 262 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 263 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 264 CHINA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 265 CHINA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 266 CHINA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 267 CHINA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 268 CHINA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 269 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 270 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 271 JAPAN SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 272 JAPAN ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 273 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 274 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 275 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 276 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 277 JAPAN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 278 JAPAN DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 279 JAPAN FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 280 JAPAN CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 281 JAPAN COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 282 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 283 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 284 INDIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 285 INDIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 286 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 287 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 288 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 289 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 290 INDIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 291 INDIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 292 INDIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 293 INDIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 294 INDIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 295 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 296 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 297 AUSTRALIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 298 AUSTRALIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 299 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 300 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 301 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 302 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 303 AUSTRALIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 304 AUSTRALIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 305 AUSTRALIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 306 AUSTRALIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 307 AUSTRALIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 308 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 310 SOUTH KOREA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 311 SOUTH KOREA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 312 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 313 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 314 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 315 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 316 SOUTH KOREA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 317 SOUTH KOREA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 318 SOUTH KOREA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 319 SOUTH KOREA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 320 SOUTH KOREA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 321 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 322 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 323 INDONESIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 324 INDONESIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 325 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 326 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 327 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 328 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 329 INDONESIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 330 INDONESIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 331 INDONESIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 332 INDONESIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 333 INDONESIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 334 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 335 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 336 PHILIPPINES SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 337 PHILIPPINES ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 338 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 339 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 340 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 341 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 342 PHILIPPINES PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 343 PHILIPPINES DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 344 PHILIPPINES FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 345 PHILIPPINES CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 346 PHILIPPINES COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 347 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 348 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 349 THAILAND SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 350 THAILAND ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 351 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 352 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 353 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 354 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 355 THAILAND PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 356 THAILAND DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 357 THAILAND FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 358 THAILAND CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 359 THAILAND COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 360 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 361 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 362 MALAYSIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 363 MALAYSIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 364 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 365 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 366 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 367 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 368 MALAYSIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 369 MALAYSIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 370 MALAYSIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 371 MALAYSIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 372 MALAYSIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 373 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 374 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 375 SINGAPORE SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 376 SINGAPORE ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 377 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 378 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 379 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 380 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 381 SINGAPORE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 382 SINGAPORE DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 383 SINGAPORE FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 384 SINGAPORE CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 385 SINGAPORE COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 386 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 387 REST OF ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 388 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 389 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 390 SOUTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 391 SOUTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 392 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 393 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 394 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 395 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 396 SOUTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 397 SOUTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 398 SOUTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 399 SOUTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 400 SOUTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 401 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 402 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 403 BRAZIL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 404 BRAZIL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 405 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 406 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 407 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 408 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 409 BRAZIL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 410 BRAZIL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 411 BRAZIL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 412 BRAZIL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 413 BRAZIL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 414 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 415 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 416 ARGENTINA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 417 ARGENTINA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 418 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 419 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 420 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 421 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 422 ARGENTINA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 423 ARGENTINA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 424 ARGENTINA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 425 ARGENTINA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 426 ARGENTINA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 427 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 428 REST OF SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 429 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 430 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 431 MIDDLE EAST AND AFRICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 432 MIDDLE EAST AND AFRICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 433 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 434 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 435 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 436 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 437 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 438 MIDDLE EAST AND AFRICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 439 MIDDLE EAST AND AFRICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 440 MIDDLE EAST AND AFRICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 441 MIDDLE EAST AND AFRICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 442 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 443 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 444 SAUDI ARABIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 445 SAUDI ARABIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 446 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 447 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 448 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 449 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 450 SAUDI ARABIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 451 SAUDI ARABIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 452 SAUDI ARABIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 453 SAUDI ARABIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 454 SAUDI ARABIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 455 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 456 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 457 SOUTH AFRICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 458 SOUTH AFRICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 459 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 460 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 461 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 462 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 463 SOUTH AFRICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 464 SOUTH AFRICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 465 SOUTH AFRICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 466 SOUTH AFRICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 467 SOUTH AFRICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 468 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 469 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 470 U.A.E SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 471 U.A.E ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 472 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 473 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 474 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 475 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 476 U.A.E PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 477 U.A.E DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 478 U.A.E FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 479 U.A.E CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 480 U.A.E COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 481 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 482 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 483 EGYPT SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 484 EGYPT ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 485 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 486 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 487 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 488 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 489 EGYPT PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 490 EGYPT DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 491 EGYPT FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 492 EGYPT CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 493 EGYPT COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 494 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 495 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 496 ISRAEL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 497 ISRAEL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 498 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 499 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 500 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 501 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 502 ISRAEL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 503 ISRAEL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 504 ISRAEL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 505 ISRAEL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 506 ISRAEL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 507 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 508 REST OF MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
Lista de figuras
FIGURE 1 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 2 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR TOXICOLOGY TESTING PRODUCTS AND RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL INDUSTRIES ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET FROM 2023 TO 2030
FIGURE 12 THE CONSUMABLES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET
FIGURE 16 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2022
FIGURE 17 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, CAGR (2023-2030)
FIGURE 19 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 20 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2022
FIGURE 21 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2020-2029 (USD MILLION)
FIGURE 22 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, CAGR (2023-2030)
FIGURE 23 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, LIFELINE CURVE
FIGURE 24 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 25 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 27 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2022
FIGURE 29 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2023-2030 (USD MILLION)
FIGURE 30 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, CAGR (2023-2030)
FIGURE 31 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, LIFELINE CURVE
FIGURE 32 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2022
FIGURE 33 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2023-2030 (USD MILLION)
FIGURE 34 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, CAGR (2023-2030)
FIGURE 35 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, LIFELINE CURVE
FIGURE 36 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 37 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 38 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 39 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 41 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION (2022)
FIGURE 42 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION (2023 & 2030)
FIGURE 43 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION (2022 & 2030)
FIGURE 44 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 45 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 46 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 47 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 48 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 49 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 50 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 51 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 52 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 53 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 54 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 55 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 56 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 57 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 58 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 59 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 60 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 61 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 62 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 63 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 64 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 65 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 66 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 67 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 68 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 69 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 70 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 71 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 72 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 73 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
